Company news

Bavarian Nordic A/S news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile

October 27, 2026

- Transactions in Connection with Share Buy-Back Program

October 19, 2026

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

October 19, 2026

- Transactions in Connection with Share Buy-Back Program

October 12, 2026

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

October 12, 2026

Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance

October 8, 2026

- Transactions in Connection with Share Buy-Back Program

October 5, 2026

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

October 5, 2026

Bavarian Nordic – Notification of Holding of Treasury Shares

September 22, 2026

Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic

September 17, 2026

Bavarian Nordic Launches First Tranche of New Share Buy-Back Program

September 1, 2026

Bavarian Nordic Reports Strong First Half 2026 Results

August 21, 2026

Bavarian Nordic to Launch New Share Buy-back Program of up to DKK 750 Million

August 21, 2026

Bavarian Nordic Upgrades its Full-Year 2026 Financial Guidance

August 21, 2026

Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years

August 7, 2026

Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil

July 13, 2026

- Completion of Share Buy-Back Program

July 13, 2026

Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine

June 29, 2026

Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine

June 9, 2026

Bavarian Nordic Announces Interim Results for the First Three Months of 2026

May 13, 2026

Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines

May 11, 2026

Resolutions of the Annual General Meeting 2026 of Bavarian Nordic A/S

April 21, 2026

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

April 20, 2026

Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine

April 16, 2026

- Transactions in Connection with Share Buy-Back Program

April 13, 2026

Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years

March 27, 2026

Bavarian Nordic A/S – Notice Convening Annual General Meeting

March 24, 2026

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

March 12, 2026

Bavarian Nordic Launches Next Tranche of Share Buy-Back Program

March 12, 2026

Bavarian Nordic Publishes Annual Report 2025

March 12, 2026

Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement

March 11, 2026

Paul Chaplin Steps Down as CEO of Bavarian Nordic

March 2, 2026

Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada

February 18, 2026

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026

February 12, 2026

Bavarian Nordic – Completion of Share Buy-Back Program

February 9, 2026

Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil

January 23, 2026

Bavarian Nordic Launches Planned Share Buy-Back Program

January 7, 2026

Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees

December 18, 2025

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic

December 17, 2025

Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million

December 2, 2025

Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen

November 26, 2025

Bavarian Nordic Announces Interim Results for the First Nine Months of 2025

November 14, 2025

Bavarian Nordic Announces Changes to the Board of Directors

November 13, 2025

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

November 10, 2025

Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed

November 6, 2025

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business

November 1, 2025

Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira

October 31, 2025

Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox

October 31, 2025

Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines

October 28, 2025

Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic

October 21, 2025

Older news releases →

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.